Sign inGet started

BIZZARI JEAN-PIERRE

Insider CIK 1630914 · HALO Director · CPXX Director · PIRS Director · ADCT Director · APRE Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
APRE Aprea Therapeutics, Inc. A Award deriv2026-06-162026-06-1712,555— $012,555SEC↗
APRE Aprea Therapeutics, Inc. A Award2026-06-162026-06-173,135— $04,180SEC↗
ADCT ADC Therapeutics SA F Tax w/h2026-06-032026-06-0312,600$3.08 $38.8K139,302SEC↗
ADCT ADC Therapeutics SA A Award2026-06-012026-06-0345,000— $0151,902SEC↗
ADCT ADC Therapeutics SA F Tax w/h2025-06-132025-06-1712,600$3.58 $45.1K106,902SEC↗
APRE Aprea Therapeutics, Inc. A Award deriv2025-06-052025-06-094,185— $04,185SEC↗
APRE Aprea Therapeutics, Inc. A Award2025-06-052025-06-091,045— $01,045SEC↗
ADCT ADC Therapeutics SA A Award2025-06-032025-06-0540,000— $0119,502SEC↗
ADCT ADC Therapeutics SA S Sale2024-06-172024-06-186,995$2.89 $20.2K79,502SEC↗
ADCT ADC Therapeutics SA A Award2024-06-132024-06-1440,000— $086,497SEC↗
APRE Aprea Therapeutics, Inc. A Award deriv2023-08-232023-08-2412,500— $012,500SEC↗
HALO HALOZYME THERAPEUTICS, INC A Award deriv2023-05-052023-05-0911,371— $011,371SEC↗
HALO HALOZYME THERAPEUTICS, INC A Award2023-05-052023-05-098,065— $066,815SEC↗
HALO HALOZYME THERAPEUTICS, INC A Award2022-05-052022-05-066,206— $058,750SEC↗
HALO HALOZYME THERAPEUTICS, INC S Sale2021-08-252021-08-2535,000$41.01 $1.44M52,544SEC↗
HALO HALOZYME THERAPEUTICS, INC A Award2021-05-052021-05-065,230— $087,544SEC↗
HALO HALOZYME THERAPEUTICS, INC A Award2020-04-302020-05-018,829— $082,314SEC↗
PIRS PIERIS PHARMACEUTICALS, IN A Award deriv2020-01-252020-01-2820,000— $020,000SEC↗
HALO HALOZYME THERAPEUTICS INC A Award2019-05-022019-05-0312,173— $073,485SEC↗
PIRS PIERIS PHARMACEUTICALS, IN A Award deriv2019-01-252019-01-2920,000— $020,000SEC↗
HALO HALOZYME THERAPEUTICS INC A Award2018-05-022018-05-0210,363— $061,312SEC↗
PIRS PIERIS PHARMACEUTICALS, IN A Award deriv2018-01-252018-01-2920,000— $020,000SEC↗
HALO HALOZYME THERAPEUTICS INC A Award2017-05-042017-05-0514,135— $050,949SEC↗
PIRS PIERIS PHARMACEUTICALS, IN A Award deriv2017-01-252017-01-3020,000— $020,000SEC↗
CPXX Celator Pharmaceuticals In D To issuer deriv2016-07-122016-07-1228,000$27.48 $769.4K0SEC↗
CPXX Celator Pharmaceuticals In D To issuer deriv2016-07-122016-07-1214,000$27.65 $387.1K0SEC↗
HALO HALOZYME THERAPEUTICS INC A Award2016-05-042016-05-0620,202— $036,814SEC↗
PIRS PIERIS PHARMACEUTICALS, IN A Award deriv2016-02-162016-02-1820,000— $020,000SEC↗
CPXX Celator Pharmaceuticals In A Award deriv2015-06-112015-06-1514,000— $014,000SEC↗
HALO HALOZYME THERAPEUTICS INC A Award2015-05-062015-05-0713,175— $016,612SEC↗
CPXX Celator Pharmaceuticals In A Award deriv2015-02-272015-03-0328,000— $028,000SEC↗
HALO HALOZYME THERAPEUTICS INC A Award2015-01-172015-01-213,437— $03,437SEC↗